Additionally, the binding capacity of HDL and APOA-I to both ABCA1 and SR-BI transporters is significantly compromised in AD patients [76], indicating that APOA-I not only exhibits altered expression levels but also demonstrates impaired cholesterol transport capacity in AD patients. Here, APOA1 is linked to Alzheimer disease.